BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jul 28, 2003
 |  BioCentury  |  Product Development

Roche's product deal flow

Roche's product deal flow

Date Partner Disease area Status at time of deal Deal
4/9/02 Isotechnika (TSE:ISA) Autoimmune/Inflammation, Transplant Ph II Will co-develop ISA's ISA247, a calcineurin inhibitor immunosuppressant in Phase II testing for renal transplantation and psoriasis.
7/22/03 Cardion Autoimmune/Inflammation, Transplant Preclinical ROCZ will acquire Cardion's IL-15 cytokine...

Read the full 314 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >